These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura. Bettoni G; Palla R; Valsecchi C; Consonni D; Lotta LA; Trisolini SM; Mancini I; Musallam KM; Rosendaal FR; Peyvandi F J Thromb Haemost; 2012 Aug; 10(8):1556-65. PubMed ID: 22672482 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Kremer Hovinga JA; Heeb SR; Skowronska M; Schaller M J Thromb Haemost; 2018 Apr; 16(4):618-629. PubMed ID: 29356300 [TBL] [Abstract][Full Text] [Related]
8. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. Thomas MR; de Groot R; Scully MA; Crawley JT EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702 [TBL] [Abstract][Full Text] [Related]
9. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. Saha M; McDaniel JK; Zheng XL J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310 [TBL] [Abstract][Full Text] [Related]
10. Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura. Scheiflinger F; Knöbl P; Trattner B; Plaimauer B; Mohr G; Dockal M; Dorner F; Rieger M Blood; 2003 Nov; 102(9):3241-3. PubMed ID: 12855569 [TBL] [Abstract][Full Text] [Related]
12. Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura. De Waele L; Sakai K; Mancini I; Sinkovits G; Falter T; Inoue T; Agosti P; Rossmann H; Von Auer C; Tersteeg C; De Meyer SF; Joly BS; Veyradier A; Coppo P; Fijnheer R; Peyvandi F; Prohászka Z; Lämmle B; Vanhoorelbeke K J Thromb Haemost; 2024 Feb; 22(2):493-502. PubMed ID: 37866519 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo. Shelat SG; Smith P; Ai J; Zheng XL J Thromb Haemost; 2006 Aug; 4(8):1707-17. PubMed ID: 16879212 [TBL] [Abstract][Full Text] [Related]
15. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura. Mancini I; Ricaño-Ponce I; Pappalardo E; Cairo A; Gorski MM; Casoli G; Ferrari B; Alberti M; Mikovic D; Noris M; Wijmenga C; Peyvandi F; J Thromb Haemost; 2016 Dec; 14(12):2356-2367. PubMed ID: 27762046 [TBL] [Abstract][Full Text] [Related]
16. Impact of N-glycan mediated shielding of ADAMTS-13 on the binding of pathogenic antibodies in immune thrombotic thrombocytopenic purpura. Postmus T; Graça NAG; Ferreira de Santana J; Ercig B; Langerhorst P; Luken B; Joly BS; Vanhoorelbeke K; Veyradier A; Coppo P; Voorberg J J Thromb Haemost; 2023 Dec; 21(12):3402-3413. PubMed ID: 37633643 [TBL] [Abstract][Full Text] [Related]
17. Lupus nephritis combined with renal injury due to thrombotic thrombocytopaenic purpura-haemolytic uraemic syndrome. Yu F; Tan Y; Zhao MH Nephrol Dial Transplant; 2010 Jan; 25(1):145-52. PubMed ID: 19703836 [TBL] [Abstract][Full Text] [Related]
18. Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura. Peyvandi F; Scully M; Kremer Hovinga JA; Knöbl P; Cataland S; De Beuf K; Callewaert F; De Winter H; Zeldin RK J Thromb Haemost; 2017 Jul; 15(7):1448-1452. PubMed ID: 28445600 [TBL] [Abstract][Full Text] [Related]
19. Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura. Velásquez Pereira LC; Roose E; Graça NAG; Sinkovits G; Kangro K; Joly BS; Tellier E; Kaplanski G; Falter T; Von Auer C; Rossmann H; Feys HB; Reti M; Prohászka Z; Lämmle B; Voorberg J; Coppo P; Veyradier A; De Meyer SF; Männik A; Vanhoorelbeke K J Thromb Haemost; 2021 Feb; 19(2):478-488. PubMed ID: 33171004 [TBL] [Abstract][Full Text] [Related]
20. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment. Li A; Khalighi PR; Wu Q; Garcia DA J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]